Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
HUMANA INCBullish
Humana has entered into a new joint venture agreement with BlackRock, replacing its existing partnership with WCAS through BlackRock's acquisition of a stake valued at approximately $2.8 billion. The company expects this transaction to reduce balance sheet liabilities by eliminating put options and lower its cost of capital, while affirming its 2026 adjusted EPS guidance of at least $9.00.…more
HUMANA INC
Humana Inc. announced that it has exceeded its goal of achieving Top Quartile results in the 2027 Medicare Advantage Star Ratings. The company also reaffirmed its fiscal year 2026 adjusted earnings per common share (Adjusted EPS) guidance of at least $9.00.…more
HUMANA INC
Kurt J. Hilzinger, an insider at Humana Inc., reported a change in beneficial ownership of company securities effective September 30, 2026. This filing serves as a standard Form 4 disclosure regarding the insider's stock holdings.…more
12 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
UnitedHealth Sees Medicaid Margins Bottoming in 2026
UnitedHealth Group expects its Medicaid business margins to reach a trough in 2026 before recovering to target levels by 2028. The company is also focusing on network optimization and favorable Medicare Advantage ratings to manage rising medical costs.…more
●●●●●●●● ●●●●● ●●●●●●
Humana has entered a new joint venture with BlackRock to manage its CenterWell clinics, aiming to reduce capital costs and improve its balance sheet. The company also reaffirmed its adjusted EPS guidance of at least $9.00 for fiscal year 2026.…more
●●●●●●●● ●●●●● ●●●●●●
DataMeds AI's 'ChemoFx' cancer assay has been added to Humana's Medicaid coverage policy. Investors are reacting positively to the expanded payer coverage, which is expected to improve test adoption and revenue visibility.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.